Doctor profile · Federal record

Dr. Emily Fridlington, MD

Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Adolescent Medicine (Internal Medicine) Physician · San Antonio, TX

  • NPI 1528262185
  • Accepts Medicare
  • MIPS 86.3 / 100 · 2023
  • 20 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
131 W Sunset RD Ste 101
San Antonio, TX 782092797
(210) 255-8447
fax (210) 255-8446
Additional location
121 Bulverde Crossing RD Ste 110
Bulverde, TX 781636201
(830) 380-3031
fax (866) 325-0543

Credentials & registration

NPPES · NUCC
NPI registered
June 2007 — 19 yrs on file
Profile last updated
July 11, 2023
Year of graduation
2006 — 20 yrs since
Specialty taxonomy
207N00000X — NUCC code
State licenses (3)
Texas #P2644 · Iowa #37782 · Texas #BP10026398

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1528262185. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,879
Distinct HCPCS
10
Medicare allowed
$162,608
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,182 199 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 518 380 $86
17000 Destruction of precancer skin growth, 1 growth 304 251 $54
99214 Established patient office or other outpatient visit, 30-39 minutes 230 169 $123
17110 Destruction of skin growth, 1-14 growths 159 136 $106
17004 Destruction of precancer skin growth, 15 or more growths 119 96 $161
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 76 25 $1
11102 Biopsy of related skin growth, first growth 75 70 $90
11900 Injection into skin growth, 1-7 growths 61 25 $48
99203 New patient office or other outpatient visit, 30-44 minutes 50 50 $106

In context: peer comparison

Among 26 peers in this city , average services per provider: 409. This provider delivers 7.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,165
Transactions
49
Manufacturers
13
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, Inc. 15 $413.47
ABBVIE INC. 13 $299.63
Lilly USA, LLC 4 $92.77
Ortho Dermatologics, a division of Bausch Health US, LLC 4 $71.62
Galderma Laboratories, L.P. 1 $65.54
Novartis Pharmaceuticals Corporation 2 $36.75
Incyte Corporation 2 $34.57
Amgen Inc. 2 $34.13
Regeneron Healthcare Solutions, Inc. 2 $32.95
Arcutis Biotherapeutics, Inc. 1 $23.76
UCB, Inc. 1 $23.73
Biofrontera Inc. 1 $21.65
SUN PHARMACEUTICAL INDUSTRIES INC. 1 $14.90

By nature of payment

Food and Beverage
$1,058
Education
$107

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
537
Patients
243
Total drug cost
$63,986
Drug Type Claims Patients Total cost
Ketoconazole Generic 105 47 $1,656
Triamcinolone Acetonide Generic 84 66 $675
Finasteride Generic 62 17 $1,032
Doxycycline Hyclate Generic 34 15 $663
Clindamycin Phosphate Generic 32 11 $1,471
Clobetasol Propionate Generic 30 21 $1,882
Metronidazole Generic 29 12 $2,094
Dutasteride Generic 27 0 $784
Fluocinonide Generic 26 21 $1,677
Mupirocin Generic 24 22 $203

Frequently asked questions

Auto-generated from federal data
What is Dr. Emily Fridlington's medical specialty?
Dr. Emily Fridlington practices Dermatology Physician in San Antonio, TX.
Where does Dr. Emily Fridlington practice?
Dr. Emily Fridlington practices at 131 W Sunset RD Ste 101, San Antonio, TX 782092797. Office phone: 2102558447.
What is Dr. Emily Fridlington's NPI?
Dr. Emily Fridlington's National Provider Identifier (NPI) is 1528262185, issued by NPPES.
Does Dr. Emily Fridlington accept Medicare assignment?
Yes. Dr. Emily Fridlington accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Emily Fridlington commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.